Physician profile
Robert W Hegerman
NPI 1275622482
$1,687.28
in general payments reported to CMS, 2019-2025
12 companies · $827 in 2025
The $827 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $26.42 · 2021: $42.29 · 2022: $160 · 2023: $79.71 · 2024: $398 · 2025: $827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $782 · Education: $500 · Entertainment: $22.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $781.68 |
| Education | $500.00 |
| Entertainment | $22.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $574.81 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $438.45 | 2019-2025 | Total30, Precision7, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $281.81 | 2019-2025 | |
| Lumenis Be INC | $160.32 | 2025 | Optilight |
| Oyster Point Pharma, INC. | $48.48 | 2022-2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $41.66 | 2020-2024 | |
| Glaukos Corporation | $40.14 | 2025 | Idosetr |
| Alcon Research LLC | $31.41 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $23.05 | 2025 | Xdemvy |
| Optos, INC. | $22.52 | 2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Novartis Pharmaceuticals Corporation | $12.62 | 2022 | |
| Synergeyes, INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Hegerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.